+Search query
-Structure paper
Title | Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines. |
---|---|
Journal, issue, pages | Oncoimmunology, Vol. 6, Page e1277306-e1277306, Year 2017 |
Publish date | Oct 21, 2016 (structure data deposition date) |
Authors | Klein, C. / Waldhauer, I. / Nicolini, V.G. / Freimoser-Grundschober, A. / Nayak, T. / Vugts, D.J. / Dunn, C. / Bolijn, M. / Benz, J. / Stihle, M. ...Klein, C. / Waldhauer, I. / Nicolini, V.G. / Freimoser-Grundschober, A. / Nayak, T. / Vugts, D.J. / Dunn, C. / Bolijn, M. / Benz, J. / Stihle, M. / Lang, S. / Roemmele, M. / Hofer, T. / van Puijenbroek, E. / Wittig, D. / Moser, S. / Ast, O. / Brunker, P. / Gorr, I.H. / Neumann, S. / de Vera Mudry, M.C. / Hinton, H. / Crameri, F. / Saro, J. / Evers, S. / Gerdes, C. / Bacac, M. / van Dongen, G. / Moessner, E. / Umana, P. |
External links | Oncoimmunology / PubMed:28405498 |
Methods | X-ray diffraction |
Resolution | 2.3 Å |
Structure data | PDB-5m5e: |
Chemicals | ChemComp-MAN: ChemComp-SO4: ChemComp-CYS: ChemComp-NAG: ChemComp-HOH: |
Source |
|
Keywords | IMMUNE SYSTEM / Interleukine-2 / interleukine-2 receptor / cytokine / interleukine-2 variant |